A new device developed by Stanford University researchers could make it easier for doctors to monitor the success of blood vessel surgery.
In a small trial, brain scans revealed who was most at risk of relapsing after being treated for addiction to stimulants like amphetamines or cocaine. The finding could identify people who need help staying drug-free.
Scientists at Stanford have solved a 50-year-old mystery that could open up new areas of research into muscle disorders. The study revealed a human enzyme that modifies muscle proteins to help them grow and remain strong.
Physical therapy within three months of a musculoskeletal pain diagnosis reduced patients’ risk of long-term opioid use by about 10 percent, according to a study by researchers at Stanford and Duke.
Stanford researchers have developed a way to watch brain cells send electrical signals using only light, a few lenses and other optical elements, and a fast video camera.
People who submit their DNA for analysis receive information that not only predicts their risk for disease but, in some cases, might influence that risk, according to a recent study by researchers at Stanford University.
To treat diabetes directly, rather than manage its symptoms, doctors need a way to get drugs to cells that produce insulin. The key, Stanford researchers report, may be those cells’ affinity for zinc.
A widely used chemotherapy drug, methotrexate, causes a complex set of problems in three major cell types within the brain’s white matter, leading to 'chemo brain' or cognitive impairment, researchers say.
Researchers at Stanford and the University of Oregon discovered that virtual reality (VR) can be a powerful tool for improving environmental learning gains and attitudes.
Researchers have identified the key molecular players in a call's decision to repair a damaged protein or destroy it, a first step toward treating many human diseases, including Alzheimer’s, Parkinson’s and cancers.